Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Canine distemper virus (CDV) is an **enveloped, negative-sense single-stranded RNA virus** in the **genus Morbillivirus** and the **family Paramyxoviridae**[7][4]. It is a highly contagious and often lethal pathogen for domestic dogs and a wide spectrum of wild and captive carnivores and other mammals[7][4]. CDV is closely related to the viruses causing measles in humans and rinderpest in cattle[7]. The viral genome encodes several structural and nonstructural proteins, including nucleocapsid (N), phospho (P), matrix (M), fusion (F), large polymerase (L), and hemagglutinin (H), with H and F proteins being key for cell entry via interaction with the host's SLAM (CD150) and Nectin-4 receptors[1][3][4][2]. Disease manifests typically as severe respiratory, gastrointestinal, and neurological symptoms; it is vaccine-preventable but remains a significant threat where immunization rates are low[7]. CDV is not a molecular drug target like a receptor or enzyme, but is itself the pathogen targeted by vaccines. **Explanation of Correctness:** "Canine distemper virus" is *not* a molecular drug target such as a receptor, enzyme, or transporter; it is a virus as a whole organism. Its proteins (notably the hemagglutinin [H] protein or fusion [F] protein) might be molecular targets for antivirals or antibodies, but "Canine distemper virus" as a term is imprecise for molecular targeting contexts, and the answer is therefore flagged as “is_incorrect: true” for this framework. If a specific viral protein (e.g., "Canine distemper virus hemagglutinin") is intended, please specify for proper molecular annotation.
Null (Not a molecular target for therapeutic drugs; vaccines work by priming the immune system against viral antigens)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Canine distemper virus (CDV).